[go: up one dir, main page]

HK1162302A1 - 用以打通受阻塞生物导管的弹性蛋白酶 - Google Patents

用以打通受阻塞生物导管的弹性蛋白酶 Download PDF

Info

Publication number
HK1162302A1
HK1162302A1 HK12102287.4A HK12102287A HK1162302A1 HK 1162302 A1 HK1162302 A1 HK 1162302A1 HK 12102287 A HK12102287 A HK 12102287A HK 1162302 A1 HK1162302 A1 HK 1162302A1
Authority
HK
Hong Kong
Prior art keywords
composition
elastase
conduit
biological conduit
patient
Prior art date
Application number
HK12102287.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1162302B (zh
Inventor
Nicholas F. Franano
Original Assignee
Proteon Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteon Therapeutics, Inc. filed Critical Proteon Therapeutics, Inc.
Publication of HK1162302A1 publication Critical patent/HK1162302A1/zh
Publication of HK1162302B publication Critical patent/HK1162302B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/486—Elastase (3.4.21.36 or 3.4.21.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
HK12102287.4A 1999-09-24 2012-03-07 用以打通受阻塞生物導管的彈性蛋白酶 HK1162302B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15593899P 1999-09-24 1999-09-24
US155938P 1999-09-24

Publications (2)

Publication Number Publication Date
HK1162302A1 true HK1162302A1 (zh) 2012-08-31
HK1162302B HK1162302B (zh) 2015-08-28

Family

ID=

Also Published As

Publication number Publication date
DK1923068T3 (da) 2011-06-27
WO2001021574A1 (en) 2001-03-29
EP1220830B1 (en) 2007-05-02
EP1220830A1 (en) 2002-07-10
CA2385488C (en) 2015-07-07
EP1923068B1 (en) 2011-06-08
PT1923068E (pt) 2011-07-29
EP2332568A1 (en) 2011-06-15
AU7612100A (en) 2001-04-24
PT2363142E (pt) 2015-08-04
CY1106656T1 (el) 2012-01-25
ES2534938T3 (es) 2015-04-30
EP2363142A9 (en) 2011-10-19
CA2385488A1 (en) 2001-03-29
CY1112329T1 (el) 2015-12-09
WO2001021574A9 (en) 2002-12-27
ES2364191T3 (es) 2011-08-26
JP5763286B2 (ja) 2015-08-12
DK2363142T3 (en) 2015-04-20
EP1220830A4 (en) 2005-03-30
JP2003523319A (ja) 2003-08-05
ES2284528T3 (es) 2007-11-16
ATE511854T1 (de) 2011-06-15
DE60034694D1 (de) 2007-06-14
EP1923068A1 (en) 2008-05-21
CY1117932T1 (el) 2017-05-17
EP2363142B8 (en) 2015-06-10
DK1220830T3 (da) 2007-07-16
JP2012131830A (ja) 2012-07-12
PT1220830E (pt) 2007-06-11
EP2363142B1 (en) 2015-03-25
JP5793461B2 (ja) 2015-10-14
DE60034694T2 (de) 2008-01-17
ATE361095T1 (de) 2007-05-15
EP2363142A1 (en) 2011-09-07

Similar Documents

Publication Publication Date Title
US8562983B2 (en) System comprising elastase
JP5793461B2 (ja) 閉塞した生物学的管を開通するためのシステムと方法
Welch et al. Infected false aneurysms in the groin of intravenous drug abusers
US10179163B2 (en) Methods of treatment with elastase
JP2011001379A (ja) 生体導管の疾患を治療および予防するための方法
HK1162302B (zh) 用以打通受阻塞生物導管的彈性蛋白酶
Gu et al. Toe-to-hand transfer: an analysis of 14 failed cases
RU2222269C2 (ru) Способ лечения панкреонекроза
EP1807108A2 (en) Methods for the treatment and prevention of diseases of biological conduits
Ferrara et al. EFFICACY, SAFETY AND OUTCOMES OF “INJECT AND CUT” ENDOSCOPIC MUCOSAL RESECTION (EMR) FOR LARGE SESSILE AND FLAT COLORECTAL POLYPS
Gerard et al. Hepatic Artery Ligation and Portal Vein Infusion

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190924